Fennec Pharmaceuticals Inc.

TSX:FRX.TO

Biotechnology

Healthcare
$19.17 -1.71%

-$0.22 today

Market cap
$676.80M
Beta
1.08
P/E (TTM)
-36.5
EPS (TTM)
-$0.24
52W Low $7.59High $14.24

Volume 0.00M

Average 0.00M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$14.67M

FY 2025 · Annual

Investing Cash Flow

$0.00

FY 2025 · Annual

Financing Cash Flow

$25.01M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(17.35M)(23.71M)(16.05M)(436K)(9.74M)
Depreciation & Amortization000800K103K
Deferred Income Tax00000
Stock-Based Compensation4.02M4.22M5.35M5.06M7.03M
Change in Working Capital(932K)1.1M(6.78M)16.94M(12.04M)
Accounts Receivables0(1.55M)(7.27M)(7.87M)(12.44M)
Inventory0(576K)(1.58M)579K(1.28M)
Accounts Payables(794K)1.61M1.39M(537K)1.39M
Other Working Capital(138K)1.61M683K24.77M282K
Other Non-Cash Items307K466K326K4.61M(26.45K)
Operating Cash Flow(14.22M)(18.06M)(17.14M)26.98M(14.67M)
Capital Expenditures00000
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow00000
Debt Repayment5M19.94M5M(13M)(19.82M)
Common Stock Issued000045.01M
Common Stock Repurchased0(194K)(78K)(176K)0
Dividends Paid00000
Other Financing Activities(22K)797K1.64M(439K)(190.27K)
Financing Cash Flow4.98M20.73M6.64M(13.62M)25.01M
Effect of Forex Changes0000(1.5M)
Net Change in Cash(9.24M)2.67M(10.51M)13.37M8.83M
Free Cash Flow(14.22M)(18.06M)(17.14M)26.98M(14.67M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$9.7M
+ D&A$103.0K
+ Stock-Based Comp$7.0M
+ Deferred Tax$0
- Working Capital-$12.0M
- Other Non-Cash-$26.4K
= Operating Cash Flow-$14.7M
- Capex$0
= Free Cash Flow-$14.7M

Analysis

FY2025 free cash flow is -$14.7M. FCF conversion is 150.6% of net income. Operating cash flow was -$14.7M, with capex of $0. The largest bridge item is Working Capital at -$12.0M.

Recent Filings

Recent regulatory filings

No filings found.

Does FRX.TO generate free cash flow?

Fennec Pharmaceuticals Inc. (FRX.TO) generated -$14.67M of free cash flow in fiscal 2025.

How much operating cash flow does FRX.TO produce?

Operating cash flow was -$14.67M, before capital expenditures of $0.00.